Evaluation of Intravitreal Bevacizumab Upload and Followed by Dexamethasone Implant Monotherapy for Macular Edema due to Retinal Vein Occlusions
Author: Yusuf Ziya Güven (Turkey)
Co-authors: Fahrettin Akay
Purpose
To investigate the functional and anatomical outcomes of intravitreal bevacizumab (IVB) upload followed by intravitreal dexamethasone implant (IVD) monotherapy treatment for macular edema due to central/branch retinal vein occlusion (CRVO/BRVO).
Setting/Venue
Retrospective/İzmir Katip Çelebi University Ataturk Training and Research Hospital Eye Department
Methods
Sixty eyes of 60 treatment-naive patients with centre-involving macular edema secondary to RVO were retrospectively were included the study. All patients were treated with three upload doses of 1,25 mg IVB monthly which followed by the two 700 µg IVD doses given at 3-month intervals. Monthly follow-up was conducted for 9 months after the first injection.and were followed for at least 12 months. Main outcome measures were changes in best-corrected visual acuity (BCVA) and central foveal thickness (CFT).
Results
The data of 60 patients were analyzed. There was 33 CRVO and 27 BRVO cases. Best-corrected visual acuity changes from the baseline to nine month follow-up were significantly higher in BRVO group (P =0,03). In addition, nonsignificant differences were observed in central macular thickness in BRVO group B throughout the study period (P = 0.298).
Conlusions
For macular edema secondary to RVO, IVB administered monthly and IVD administered PRN at 3-month intervals, yielded functionally and anatomically preferable outcomes at 12 months.